• English
• German
• French
• Spanish
• Russian
• Romanian

English

Friendlyway Reaches Significant Milestone with its 5,000th Unit Deployment

Friendlyway’s Interactive Information Stations have been effectively deployed at trade shows, events, conventions and product launches.

San Francisco, CA August 26, 2004 -- Friendlyway, Inc., (www.friendlywayinc.com) developer and marketer of self-service solutions for friendly customer communication, announced today that it has reached a significant milestone with its 5,000th unit deployment. friendlyway’s Interactive Information Stations (IIS)™ are regarded as the most highly recognized system for trade shows, events, conventions and product launches. They have supplied over 100 fortune 1000 businesses including: health care companies Pfizer, J&J, Merck to technology companies Microsoft, Intel, Cisco, to entertainment companies MTV, ESPN, NFL Football, to financial companies BoA, Fidelity Investments, Bloomberg, to BMW, Boeing and more.

“We are extremely proud of reaching this significant milestone,” said friendlyway President and Chief Executive Officer, Alexander von Welczeck. “Our Certified Rental Partner Network is unique within the self-service industry and it allows us to provide temporary systems with a consistent, high quality customer experience around the world through our team of top quality partners in Asia, Europe and America.”

“We believe our systems offer a valuable, compelling experience for customers and are stylishly designed, durable and mobile. Over the past two years, our systems have been deployed at major venues including: CeBit Trade Fair, The Boston Marathon, 2004 Democratic National Convention and major PGA golf events.

"You can really see the impact of interactive self-service kiosk technologies at events," says Teresa Sullivan, an event planner and member of Meeting Professionals International. "The ability to present and collect information on site in a fun and interesting way provides a huge advantage for my clients." Eric Williams, MarCom Manager for Boston Scientific Neurovascular Division reported, “After utilizing the stations over the past 10 months at 9 of the targeted 11 events, we have achieved a 50% adoption rate [of a new product in less than 2 years. If we stay on this track, we could easily cut in half, the 7 to 10 year average time span for achieving market adoption.”

Friendlyway’s rental business provides the Company with a steady recurring revenue stream while increasing visibility for system sales activity, providing an integral part of the Company’s growth. Recently, the Company announced the signing of a Share Exchange Agreement with Biofarm, Inc. (OTCBB: BIOF). For more information on friendlyway’s core business, market trends and opportunities, and future growth strategies visit the Wall Street Reporter at (http://www.wallstreetreporter.com/profiles/Friendlyway.html) for an interview conducted with Alexander von Welczeck on August 23, 2004. Also to review Time Magazine's article on friendlyway visit (http://www.friendlyway.com).

Safe Harbor Statement:
Biofarm, Inc. is a holding company with headquarters in Linfield, Pennsylvania. This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended including statements regarding growth in Friendlyway’s target market and the anticipated closing of the reverse merger. Investors are cautioned that all forward-looking statements involve risks and uncertainty. While these statements are made to convey to the public Biofarm’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. While management believes such representations to be true and accurate based on information available to Biofarm at this time, actual results may differ materially from those described. In addition to the matters described in this press release, risk factors listed from time to time in Biofarm’s SEC reports and filings, including, but not limited to, its report of Form 10QSB for the quarters ended January 31, 2004 and April 30, 2004, and its report on Form 10KSB for the year ended October 31, 2003, may affect the results to be achieved.